New training aims to help prostate cancer patients speak up about sexual health
NCT ID NCT07655557
First seen Jun 24, 2026 · Last updated Jul 02, 2026 · Updated 3 times
Summary
This pilot study tests a communication skills training program called Starting the Conversation for prostate cancer patients who are bothered by sexual problems. About 100 men will either receive the training or a general health education program. The goal is to see if the training is feasible and helps patients bring up sexual health concerns during doctor visits.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Starting the Conversation (STC) - a slideshow, workbook, and resource guide
- What this could lead to
- If it works, this could help prostate cancer patients feel more comfortable discussing sexual health with their doctors, potentially improving their quality of life.
- What could go wrong
- This is a very early pilot study with only 100 people, focused on feasibility, not on proving the training works. It may not lead to any change in patient outcomes.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PROSTATE CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
NYU Langone Health
New York, New York, 10016, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a new tracer light up hidden prostate cancer?
- Could deep breaths before surgery ward off Post-Op confusion?
- A second look: MRI screening may spot hidden prostate cancers
- Can precision protons spare the bowel in prostate cancer?
- AI coaches doctors on cancer risk talks
- Can an immune booster make hormone therapy work better against prostate cancer?